Table 2.
Full-scale Intelligence Quotient scores averageda from ages 5 and 8 years according to covariates among mother-child dyads with child race, according to covariates: the HOME study (2003–2006)
| Non-Hispanic Black | Non-Hispanic White | |||
|---|---|---|---|---|
| Variable | n | Mean ± SD | n | Mean ± SD |
| Overall | 90 | 91 ± 13 | 145 | 107 ± 12 |
| Maternal age (years) | ||||
| <25 | 45 | 89 ± 15 | 8 | 101 ± 14 |
| 25 to <35 | 40 | 91 ± 11 | 104 | 107 ± 12 |
| 35+ | 5 | 103 ± 13 | 33 | 108 ± 13 |
| Maternal education | ||||
| High school or less | 51 | 88 ± 14 | 7 | 98 ± 17 |
| Some college | 31 | 92 ± 13 | 37 | 103 ± 13 |
| Completed college | 8 | 102 ± 5.9 | 101 | 109 ± 11 |
| Annual income | ||||
| <$30,000 | 70 | 89 ± 14 | 9 | 98 ± 19 |
| $30,000 to $75,000 | 17 | 95 ± 11 | 55 | 104 ± 12 |
| ≥$75,000 | 3 | 103 ± 6.6 | 81 | 110 ± 10 |
| Maternal smokingb | ||||
| Unexposed | 5 | 96 ± 7.2 | 66 | 106 ± 12 |
| Secondhand smoking | 40 | 91 ± 12 | 71 | 107 ± 13 |
| Active smoking | 45 | 91 ± 17 | 8 | 111 ± 17 |
| Parity | ||||
| 0 | 29 | 88 ± 14 | 73 | 109 ± 13 |
| 1 | 29 | 91 ± 13 | 46 | 107 ± 10 |
| 2+ | 32 | 93 ± 13 | 26 | 103 ± 12 |
| Prepregnancy BMI (kg/m2) | ||||
| Normal/underweight: <25 | 32 | 88 ± 15 | 83 | 108 ± 12 |
| Overweight: ≥25 to <30 | 23 | 95 ± 11 | 38 | 107 ± 13 |
| Obese: ≥30 | 35 | 90 ± 13 | 24 | 104 ± 14 |
| Child sex | ||||
| Male | 33 | 89 ± 13 | 69 | 105 ± 13 |
| Female | 57 | 92 ± 14 | 76 | 109 ± 12 |
aAverage FSIQ values represent the arithmetic mean of repeated child FSIQ scores. In cases where children only had one FSIQ measure, that value was used to represent the mean. Of the full analytic sample (n = 253), n = 169 children had two measures of FSIQ ascertained at 5 and 8 yrs (67%).
bMaternal smoking during pregnancy estimated based on maternal serum cotinine concentrations during pregnancy. Unexposed smoking exposure defined as having serum cotinine concentrations <0.015 ng/mL, secondhand smoking exposure is defined by serum cotinine concentrations between 0.015 and <3.00 ng/mL, and active smoking includes those with serum cotinine concentrations ≥3.00 ng/mL.